Cecropin vs PGLa — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Cecropins are a family of antimicrobial peptides first discovered in 1980 by Hans Boman in the silkmoth Hyalophora cecropia. Cecropin A was the first AMP characterized from an insect, establishing the paradigm of innate immune peptide-based defense....
Calculate Cecropin dose →PGLa is a 22-residue alpha-helical antimicrobial peptide co-isolated with magainin-2 from the skin of the African clawed frog Xenopus laevis. Individually, PGLa and magainin-2 show modest antimicrobial activity, but when combined at equimolar ratios, they exhibit synergistic kill...
Calculate PGLa dose →| Parameter | Cecropin | PGLa |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Preclinical |
| Half-Life | Minutes (proteolytic) | Minutes (proteolytic) |
| Typical Dose | N/A | N/A |
| Frequency | N/A | N/A |
| Route | Research only | Research only |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.